Quantcast

ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech

February 6, 2009

CHARLES TOWN, W.Va., Feb. 6 /PRNewswire/ — ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic and silver based treatments for diabetic peripheral neuropathy and Molluscum Contagiosum today announced it is in the process of changing its name to American Med Tech.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

“In an effort to ferret out the suspected naked short sellers and to get an accurate investor count to help our stock price accurately reflect its real value, we are changing the name of the company,” said David Phillips, Ph.D. CEO.

Additionally, Dr. Phillips reported: “This will generate a new cusip # and new stock ticker symbol. This may result in current stockholders submitting their certificates to exchange for new ones. I suggest that anyone who owns our stock and has let their broker hold it in a so called ‘street name’ request to have their certificates delivered to them so that they can update their certificates and make sure that their broker actually bought the shares for them. We have had reports that brokers have sold shares that they do not actually have.”

Finally, Dr. Phillips told reporters today: “We will have much more positive news to report in the coming days and weeks.”

Inquiries can be made at www.americanmedtech.com or www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.


Source: newswire



comments powered by Disqus